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INTRODUCTION
It is the purpose of this paper to determine if a
re1e"tionship exists bet"ween the initial peripheral blood
smear and bone marrow findings and the eventual prognosis
of a pa tj.ent with chronic lymphocytic leukemia.

In this

paper prognosis refers to the length of survival of the
patient.
Since chronic lymphocytic leukemia is fairly common
in older patients and is compatible with life for a relatively long time, an effort will be made to determine if
such a patient's survival can be predicted with any degree
of accuracy_
The information for t.his study is derived from the
heme"tology files of the Department of Internal

)\·~edicine

and the Tumor Survey at the University of Nebraska College
of Hedicine.

This series includes patients i!lho were known

to have chronic lymphocytic leukemia and i'rho 'tlere follmveO. durin€) their clinical course.

Thj.s covers a time in-

terval from 1950 to 1963.
Each patient was evaluated as to age at diagnosis,
sex and race, date of diagnosis, associated dictgnoses,
first symptom to consultation, consultation to diagnosis,
diagnosis to first treatment and the type of treatment
used.

Data on the peripheral blood smea,r
-1-

'\lIaS

limited

to anctlysts of the hemoglobin, total white blood cell
count, retlculocytes and pIa telets.

The bone marrO'Vi

was studied for its relative cellularity, gross evaluation of plasma cells and percentage of cells in the
lymphocytic series.
DIAGNOSTIC INFOfm.IATION

Of the total 64 cases, 42 were males and 22 were
females.

This is a ratio of approximately

one female

tirfD

males to

Sixty-two of these cases were white and

0

two were Negro.
The mean age at the time of diagnosis

i'laS

67.0

yaars with the men having a meaD age of 68.0 years and
the women having a mean age of 65.1 years.

The oldest

patient in this series was 87, yea,rs and the youngest
was 38 years.

Almost 40% of the patients were in the

eighth decade (70-79).

This is graphically l"epresented
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Age at Diagnosis of Chronic Lymphocytic Leukemia in 64 cases.
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At the present tlme

1~4

while 20 are still living.

of these patlents have died
The patients that died sur-

yived an average of 3.20 years after the onset·of symptoms
and 2.76 years after the diagnosis of chronic lymphocytic leukemia. "ras confirmed.
died of diseases that 'tiere
to the leukemia.

Ten of these patients

probe~bly

not directly related

That is, seven of them died of car-

ci::"lOma and three of them from a myocardial infe.rction.
The lonGest survival in this group

nine years and 11

\u~,s

months i'lhile the shortest \-las one 1vee::':.
However, the 20 patients that are still living
already have lived an average of 5.22 years after the
onset of symptoms and 4.51 years after the confirmation
of a diagnosis of chronic

IJ~phocytic

leukemia.

The

longest survivor has already had symptoms for 15 years
'while the most recent case has had symptoms about 8 months.
When the whole group of 64 patients is analyzed, a
mean value of 3.85 years is arrived at as the length of
survival or duration of the illness after the onset of
sJ~ptoms.

A mean value of 3.31 years is the correspond-

ing period of time after a positive diagnosis was made.
Figur'e 2 represents a graphic illustratj.on of these findings.
It is this mean value of 3.31 years that the various
blood findings will be compared.

HO"ileVer, since 20 of

these patients are still living, it is obvious that the

-3-

mean value is only an absolute minimum fo!" the length
of survival.

A_s these patients continue to live this

figure will become larger.
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Duration of illness ln 64 patlents ",li th
chronic lymphocytic leukemia from the
onset of clinical symptoms.

In evaluatlng this series of patients as to their
prognosis the laboratory studies at, or as close to
the time of diagnosls as possible, were studied.

In

all cases, however, at least some laboratory data ""as
recorded before treatment was started.

Some of the

specific blood and bone marro\v values were not available for each patient.

As these particular values are

encountered, this \,lil1 be noted..

Concluslons \vill be

based only upon the available evidence.
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PERIPHERAL BLOOD SIJIEAR

A hemoglobin valv'3 Fas availe.ble on each of the

64 patients.

These values ranged from a low of 3.7 Gm.

%1'lith

to a high of 16.7 Gm.

a rrean of 11.5 Gm.

%.

Fig-

ure 3 is included to try and show Borne relationship
betltleen the initial hemoglobin value and the patient' B
length of survival a.fter diagnosis.
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The Gm. %of hemoglobin in 64 patients with
chronic lymphocytic leukemia as compared
to the length of survival after diagnosis.
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%

~

value for the white blood cell count was also

obtained on all 64 patients.

The lowest count at or

near the time of diagnosis was 4,100 per cu. mm., and
the highest count

"vT8.S

576,000 per cu. mm. with a mean

value of 82,200 per cu. mm.

Figure 4 is used to show

the relationship of the white blood cell count to the
length of survival after diagnosis.
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White blood cell counts in 64 patients with
chronic lymphocytic leukemia as compared to
the years of survival after diagnosis
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A d1fferentle,1 white cell count we,s available
on 56 patients at or near the time of d1agrosis.

A

mean value for the percentage of cells in the lymphocytic
series was 81%.

The vast majority of the cells were

mature lymphocytes or smudge cells.

Only occasi.onally

WG.s a prolyr;phocyte or lymphoblast present in the peripheral smear.
The percentage of reticulocytes was recorded in
38 patients at or near the time of diagnosis.

The

lowest value \vas 0.2% and the highest value vIas 6 .. 3%
wi th a melin of

1.4%.

The normal reticulocyte response

..,.ras considered to be betvleen 0.5% and 1.5%.

The percent-

age of ret1culocytes is compared to the patient's duration of chronic lymphocytic leukemia after diagnosiS
by figure 5.
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Reticulocytes (%) in 38 patients with chronic
lymphocytic leukemia as compared to the years
of survival after diagnosis.
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An indication of the number of platelets in all
64 patients viaS available at or near the time of diagnosis.

How"ever, in about one-half of the patients only

a gross indication of the number present was recorded.
That is, a note was made that the platelets were normal,
increased or decreased.

In the remainder of the patients

an absolute value was given.

Figure 6 shows the re1a-

tionship of the number of platelets to the years of
survival after diagnosis.

The normal platelet count

:In the peripheral blood was assumed to be 150,000-

600,000 per cu. mm.
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Number of platelets per cu. mm. in 64 patients
with chronic lymphocytic leukemia as compared
to the years of survival after diagnosis.
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BONE

~1ARr1.0W

FINDINGS

Because of the importance in diagnosis of chr.onic
lymphocytic leukemia, the bone marrow findings at or
near the time of die,gnosis were studied in 58 patients.
In six of the patients enough marrO\,l fragments were
not obtained to be of diagnostic value.
The degree of cellularity in the initial bone marrow
was recorded for 54 of the patients in thj.s series.

The

degree of cellularity was stated as being hypocellular,
moderately cellular (normal), slightly hypercellular,
moderately hypercellular or markedly hypercellular.
Figure 7 shows the relationship of the degree of oellula,ri ty to the years of survival after diagnosis.
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The ~egree of cellularity in 54 patients with
chronic lymphocytic leukemia as compared to
the years of survival after diagnosis.
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The number of plasma cells in the initial bone marrow was also evaluated in an effort to correlate it with
the length of survival after diagnosis.

A plasma cell

determination was available on only 30 of the patients
in this series.

The results were listed as being decreased,

normal or increased in number.

The normal number' of

plasma cells in the bone marrow is considered to be 0.02.0 per cu. mm. 13

However, the plasma cells were con-

sidered to be decreased if none were found on the bone
marrow examine,tion.

Figure 8 shov;'s the relationship of

the number of plasme cells in the bone marrow and the
years of survival after diagnosis.
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with chronic lymphocytic leukemia as compared
to the years of survival after diagnosis.
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The percentage of cells of the lyn:phocytic series
in the bone marrow at or near the time of diagnosis was
recorded for 58 patients in this series.

fJlost of the

cell s ,,,,ere mature lYlllphocytes \vi th a fevl prolymphocytes
and an occasional lymphoblast.

The 10\l>lest percentage of

cells in the lymphocytic series was 10% :i.n one patient
while four patients t me.rro1l1s \-lere 100;;s replaced.

The

calculated mean value was 66.2% for the entire series of
Figure 9 shows the relationship between the

patients.

percentage of cells of the lymphocytic series and the
length of survival after diagnosis.
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lYlllphocytic leukemia as compared to the years of
survival after diagnosis.
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TREA T1<!ENT

Because of the multiple forms of treatment used on
most patients, it is difficult to show any correlation
between the length of survival and treatment with any
specific agent.

A tabulated list of treatments shO'lrfs

that some form of X-ray therapy was used in 34 patients,
triethylenemelamine in 26 patients, chlorambucil (Leukeran) in seven patients, phosPhorus 32 in four patients,
nitrogen mustard in one patient, aminopterin in one patient,
cortisone in one patient, prednisone in one patient,
iodine 131 in one patient, supporting therapy in six
patients and no therapy in six patients.
DISCUSSION
In this study of 64 patients with chronic lymphocytic leukemia the mean age was determined to be 67.0
years.

The mean survival time after diagnosis was cal-

culated to be 3.31 years.

According to the U.S. Bureau

of the Census, the average person may expect to live
13.1 years lO after reaching the age of 67 years. Therefore, it would appear that chronic lymphocytic leukemia
had a marked effect upon the patientfs expected survival.
However, in order to state that this was statistically
signif'icant a control group of patients would be necessary.
-12-

In a series of 137 patients studied by Shimkin9
the mean age of onset was 54.3 years.

This is consider-

ably lower than the mean age of 67.0 years in this series.
His mean survival from the time of diagnosis to death was

3.5 years.

He found tha.t the initial leukocyte count

failed to have any correlation with the length of survival.
The longest mean survival time was reported by Osgood8
in a series of 102 patients with chronic lymphocytic leukemia who were treated with phosphorus

32

•

He determined

that the mean survival time was about seven years.

How-

ever, this vias only estimated by the "method of maximum
b was app 11_e d t 0 h~~s s t u d y b y
lik e IiILOO d " wh'~c.

m'
~~vey

11 •

The latter author has shown that survival times in leukemia follow logarithm-normal distributions.

Therefore,

if one plots the lEingth of time that a patient has had
leukemia on log paper, he can estimate the length of
his expected survival.

This method of determining sur-

vival rates was not used in this study.

Admittedly how-

ever, it would probably have given the final conclusions
more validity.
In one of the largest series reported Tivey

11

studied

1,978 patients with chronic lymphocytic or granulocytic
leukemia.

He demonstrated that there was no difference
-13-

between the survival prospects of patients with lymphocytic and patients with granulocytic leukemia.

He

showed that half of the patients will die in about
2.65 years after onset of the first clinical symptoms
and that 10% will live seven years after the onset of
the disease while 1% will survive 15 years.
In another large series of 649 patients with
chronic leukemia (both lymphocytic and. granulocytic)
l.'eported by Feinleib

1

the median duration of survival

after diagnosis was 11.65 months.
Lawrence

4 in a study of 100 patients with chronic

lymphocytic leukemia reported a mean survival of 4.5
years.
In analyzing the laboratory data of this study the
hemoglobin values l'lill be considered fil:"st. According
12
to Wasi , before the availability of radioisotope technics it was generally accepted that replacement of
erythroblasts by leukemic cells was the mechanism by
which anemia developed.

However, since the bone marrOyl

was rarely biopsied, this opinion was based almost entirely
on the histopathology of the marrow at autopsy; patients
early in the natural history of their disease were not
studied.

In Wasi t s12 study all the patients with a nor-

mal hemoglobin level had a normal amount of erythroblastic

-14-

tissue and the degree of anemia i<vas roughly correlated
\ill th

the decrease in erythroblastic tissue.
There is also a massive replacement of the myeloid

tissue as \'lell as erythroblastic tissue.
are replaced by the lymphatic tissue.

These elements

It therefore seems

reasonable that the degree of anemia would be 9roportional
to the decrease in erythroblastic tissue and hence, to the
increB,se in lymphatic tissue.

It might be expected that

a patient's prognosis could then be estimated on the basis
of the hemoglobin value.

This is assuming of course, that

the replacement of the bone marrow with lymphatic tissue
carries a poor prognosis.
The results of this study seem to give support for
the above reasoning.

On examining figure 3 it is observed

that most of the values are clustered in the upper left
triangle of the graph.

Of the 32 value,s under 12 Gm.%

22, or 69%, d:led before reaching the mean survival of 3.31
years.

Of the 32 values above 12 Gm.

%18,

or 56%, lived

longer than 3.31 years.
The peripheral lymphocyte count may also be a measure
of the amount of lymphatic tissue in the marrow and
hence, an indication of the progression and duration
12
of the disease in a specific patlent.
The expected
result might be that a high lymphocyte count indicates
a poor prognosis.

-15-

This was again shown to have some correlation.
~~en

figure 4 is studied, it is observed that most of

the values are clustered in the upper right triangle.
Of the 29 values greater than 50,000 white blood cells
per cu. mm. 16, or 55%, died before surviving 3.31 years.
Te~or

29%, of the values less than 50,000 died before

surviving 3.31 years.
The percentage of reticulocytes was also included
in this study because of its direct correlation with
erythropoietic activity_

An increase in the number of

reticulocytes in the peripheral blood is indicative of
erythropoietic hyperactivity while a decreased number
or a normal or only slightly increased number in the
presence of anemia is indicative of hypoactivity or
inadequate regenerative response. 7

Therefore, if the

marrow is replaced by lymphatic tissue, this may be
reflected in the peripheral blood by a decrease in reticulocytes.

It is the purpose of this study to see if

this would indicate a poor prognosis.
The values in figure 5 are clustered in the lower
left triangle.
of the

nO~illal

There are 14 ve.lues the.t fall outside
range of 0.5-1.5%.

Only five, or 36%,

lived longer than the mean survival time.

Ten of the

24 values, or 42%, lived longer than 3.31 years.

-16-

Thrombocytopenia is not prominent throughout the
greater part of the course in most cases of chronic
lyw.phocytic leukemia, although it commonly develops
terminally, usually as part of an aplastic syndrome of
marrow failure with accompanying failure of red cell
production. 2

If marrmv- failure is indicative of a poor

prognosis, then it is possible that a reduction in the
number of platelets in the peripheral blood may also be
associated with a poor prognosis.
The majority of values in figure 6 are clustered
in the lower left tri.angle.

Sixteen values fall outside

of the normal range of 150,000-600,000 per cu. mm.

Only

two, or 12%, of these patients lived longer than 3.31
years.

Twenty-one, or 44%, of the values within the

normal range lived longer than the mean survival period.
Because of the method used in reporting platelet determinations (decreased, normal, increased, etc.), it was
not possible to arrive at an actual mean platelet value.
Since the degree of cellularity in the bone marrow
is usually proportional to the degree of lymphatic
infiltration in chronic lymphocytic leukemia, this may
sive some indication of the patient's prognosis.

It

was also not possible to arrive at a mean cellularity
value because of the method used in reporting the

-17-

findings.

None of the patients were found to have

hypocellular marrows.
mal marrow

cell~larity

Of the seven patients with norfour, or 52%, survived longer

than the mean 3.31 years.

A better correlation was

observed in the group of 19 patients ..,Ii th markedly
hypercellular bone marrows at the time of diagnosis.
Seventeen, or 90%, of these patients died before reaching
the mean survival interval of 3.31 years.
The serum proteins in chronic lymphocytic leul:emia
may show more striking variations from normal than are
seen in other forms of leukemia.

This is to be expected

in view of the close relationship of lymphocytes to
plasma cells and other cellular components of the lymphoid
and reticulo-endothelial system, with their probable functions in elaborating antibodies' and globulins.

Nevertheless,

no consistent abnormalities of electrophorectic protein
patterns occur, and the majority of patients with
clinically mild chronic lymphocytic leulremia shmi' no
differences from normal.

At later stegee of the disease

a marked increase :tn gamma globu,lins mAy be found, or

"

the''''e may be a conspicuous hypogammaglobulinemia.3
According to Klein and Block plasma cells produce
serum antibodies.

Although there is still no uniformity

of opinion concerning the function of plasma cells, they
-18-

believe there can be little doubt that plasma cell proliferation is usually associated with elevated plasma
globulin leyels.

If this is true, then there may be

some correlation between the number of plasma cells
in the bone marrow at the time of diagnosis and the
eventual prognosis of the patient.
Only 30 patients in this series had their bone
marrow plasma cell findings recorded.

Of this number

only six were reported as being decreased.

Five of

these, or 83%, died before the mean survival period
3.31 years.

of

Only four patients had bone marrows that

showed an increase in plasma cells.

Three of these,

or 75%, also died before the mean survival period of
3.31 years.

The remaining 20 patients had a normal

number of plasma cells in their marr01rTS.
Efforts to correlate the patient's prognosis with
the percentage of cells in the lymphocytic series in
the bone marrow was also attempted.

It seems reasonable

to assume that the greater the percentage of cells in
the lymphocytic series, the greater the progression of
the disease and hence, the poorer the prognosis.
Twenty-eigbt patients had more than 70% of their
bone marrow replaced with cells in the lymphocytic series.
Sixteen, or 57%, of these died before reaching the mean

-19-

survi,val period..

Eighteen, or 60%, of the patients with

less than 70% of their marro'l:/ replaced also di,ed before
reaching the mean survival period.
It is interesting to compare these blood findings
6
with a report by Marlow of a patient who lived 29 years
with chronic lymphocytic leukemia.

His initial hemo-

globin was 75% (about 10 Gm .. %), white blood cell count
was 48,800 and the i,nitial differential showed 86%
lymphocytes.
SUMMARY

A series of 64 patients i'ii th chronic lymphocytic
leukemia was studied to determine if their prognosis
could be predicted by the peripheral blood smear and
bone marrow findings at the time of diagnosis.
The sex ratio was about 2:1 with the males predominating.
The mean age at the time of diagnosis was 67.0
years with a range of from 38 years to 87 years.
Presently, 20 of the patients are living and 44
have died.

The deceased patients lived an average of

2.76 years after diagnosis.

The living patients have

survived for a mean period of 4.51 years since being
diagnosed.

All patients :tn this series, as

have a mean survival value of 3.31 years.
-20-

8.

group,

It is this

figure that is used to compare with the various blood
findings.
Of the 32 patients with hemoglobins below 12 Gm.%
69% survived less than 3.31 years.

Fifty-six per cent

of the patients 'I'lhose hemoglobin was above 12 Gm.%
died in the same time interval.
Of the 29 patients who had white blood cell counts
higher than 50,000 per cu. mm. 55% lived less than the
mean survival time.

Those with counts below 50,000

per cu. mm. had 29% that did not live 3.31 years.
The mean value for the percentage of cells of the
lymphocytic series in the differential was 81%.
The normal reticulocyte response was considered
to be 0.5-105%.

Only 36% of the patients with values

outside of this range survived more than 3.31 years.
Forty-two per cent of the values within the normal range
lived longer than the mean survival period.
Sixteen patients had platelet counts outside the
normal range of 150,000-600,000 per cu. mm.

Twelve

per cent of these survived longer than 3.31 years.

Only

44% of the patients who had normal platelet counts survived longer than this period.
The cellularity of the bone marrow was studied in
this series of patients.

Of the seven patients with

normal cellularity 52% survived longer than the mean
-21-

period.

Ninety per cent of the patients vii th markedly

hypercellular marrows failed to survive 3.31 years.
Five out of six patients with a decreased

nu~ber

of plasma cells in their marrow died before 3.31 years.
Also, three out of four patients with an increase in
marrow plasma cells failed to survive the same period
of time.
Seventy per cent replacement of the bone marro'vV'
by cells of the lymphocytic series 't,,-as used as a figure
for 90mparison.

Fifty-seven per cent of patients with

greater marrow replacement died before 3.31 years.

Of

the patients Iii th less the.n this amount of replacement
60% diecL before the mean survi,val period was reached.

CONCLUSION
The following conclusions are based on this study
of 64 patients with chronic lymphocytic leukemia at or
near the time of diagnosis.
1.

The mean age at the time of diagnosis is substantially
higher than that reported by other investigators.
Thi.s may be due to the source of information.

The

average age of the pa.tient treated at the University
of Nebraska. College of Medicine is probably higher
than the age of patients in other serj_es.
-22-

2.

The mean duration of survival compares favorably
with values given by other authors.

3.

Within broad limits, a higher hemoglobin indicates
a better prognosis.

4.

The white blood cell count shows fair correlation
in being inversely proportional to the length of
survival.

5.

Reticulocyte, counts outside the normal range have
a poor prognosis.

6.

Platelet counts outside the normal range indicate
a poor prognosis.

7.

A markedly hypercellular bone marrOy,1 indicates a
poor prognosis.

8.

An increased or decreased

nu~ber

of plasma cells

in the bone marrow carries a poor prognosis.

9.

The percentage of cells in the lymphocytic series
gives no good indication of the eventual prognosis.
All of the conclusions in this series are based

upon the assumption that all of the patients are deceased.
This was necessary in order to obtain a series large
enough to be of some significance.

Therefore, after

all of the patients are actually deceased the conclusions
may be markedly altered.

-23-
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